Cite

HARVARD Citation

    Bajpai, D. et al. (2021). Development and longevity of antibodies against SARS‐CoV‐2 in kidney transplant recipients after symptomatic COVID‐19. Transplant infectious disease. 23 (4), p. n/a. [Online]. 
  
Back to record